Frequency, prevalence, incidence and risk factors associated with visual hallucinations in a sample of patients with Parkinson's disease: A longitudinal 4-year study

International Journal of Geriatric Psychiatry

Volumn 28, Issue 6, 2013, Pages 626-631

  Gibson, G ^a   Mottram, P G ^b   Burn, D J ^a   Hindle, J V ^c   Landau, S ^d   Samuel, M ^e   Hurt, C S ^d   Brown, R G ^d   M Wilson, K C ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c BANGOR UNIVERSITY   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e CITY UNIVERSITY   (United Kingdom)

Author keywords

frequency; incidence; Parkinson's disease; prevalence; visual hallucinations

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; DISEASE DURATION; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; PARKINSON DISEASE; PREVALENCE; RISK FACTOR; UNITED KINGDOM; VISUAL HALLUCINATION;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; GREAT BRITAIN; HALLUCINATIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PARKINSON DISEASE; PREVALENCE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS;

EID: 84877585313     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.3869     Document Type: Article

References (29)

1. Aarsland D, Larsen JP, Karlsen K, Lim NG, Tandberg E,. 1999. Mental symptoms in Parkinson's disease are important contributors to caregiver distress. Int J Geriatr Psychiatry 14 (10): 866-874.
2. th edn). APA: Washington D.C.
3. Baker WL, Silver D, White CM, et al,. 2009. Dopamine agonists in the treatment of early Parkinson's disease: a meta analysis. Parkinsonism Relat Disord 15 (4): 287-94.
4. Biglan KM, Holloway RG, McDermott MP, Richard IH,. 2007. Risk factors for somnolence, edema and hallucinations in early Parkinson's disease. Neurology 69 (2): 187-195.
5. Brown RG, Landau S, Hindle JV, et al,. 2011. Depression and anxiety related subtypes in Parkinson's disease. J Neurol Neurosurg Psychiatry 82: 803-809.
6. Copeland J, Prince M, Wilson K, Dewey M, Payne J, Gurland B,. 2002. The geriatric mental state examination in the 21st century. Int J Geriatr Psychiatry 17 (8): 729-732.
7. Diederich NJ, Fenelon G, Stebbins G, Goetz CG,. 2009. Hallucinations in Parkinson's disease. Nat Rev Neurol 5: 331-342.
8. Doe de Maindreville A, Fenelon G, Mahieux F,. 2005. Hallucinations in Parkinson's disease: a follow up study. Mov Disord 20 (2): 212-217.
9. Fenelon G, Mahieux F, Huon R, Ziegler M,. 2000. Hallucinations in Parkinson's disease. Brain 123 (4): 733-745.
10. Fenelon G, Goetz CG, Karenberg A,. 2006. Hallucinations in Parkinson's disease in the prelevodopa era. Neurology 66 (1): 93-98.
11. Fenelon G, Soulas T, de Langavant LC, Trinkler I, Bachoud-Levi A,. 2011. Feeling of presence in Parkinson's disease. J Neurol Neurosurg Psychiatry In press. Available at http://jnnp.bmj.com/content/early/2011/05/07/jnnp.2010. 234799.abstract
12. Folstein MF, Folstein SE, McHugh PR,. 1975. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (3): 189-98.
13. Forsaa EB, Larasen JP, Wentzel-larsen T, et al,. 2010. A 12 year population-based study of psychosis in Parkinson's disease. Arch Neurol 67 (8): 996-1001.
14. Goetz CG, Ouyang B, Negron A, Stebbins GT,. 2010. Hallucinations and sleep disorders in PD. Neurology 75 (20): 1773-1779.
15. Goetz CG, Stebbins GT, Ouyang B,. 2011. Visual plus non visual hallucinations in Parkinson's disease: development and evolution over 10 years. Mov Disord. 26 (12): 2196-2200.
16. Haaxma CA, Bloem BR, Borm GF, et al,. 2007. Gender differences in Parkinson's disease. J Neurol Neurosurg Psychiatry 78: 819-824.
17. Hughes AJ, Daniel SE, Kilford L, Lees AJ,. 1992. Accuracy of clinical diagnosis of idiopathic Parkinson's disease. A clinic-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181-184.
18. Inzelberg R, Kipervasser S, Korczyn AD,. 1998. Auditory hallucinations in Parkinson's disease. J Neurol Neurosurg Psychiatry 64 (4): 533-535.
19. Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N,. 1997. The PDQ-8. Development and validation of a short form Parkinson's disease questionnaire. Psychol Health 12 (6): 805-814.
20. Merims D, Shabtai H, Korczyn AD, Peretz C, Weizman N, Giladi N,. 2004. Antiparkinsonian medication is not a risk factor for the development of hallucinations in Parkinson's disease. J Neural Transm 111 (10): 1447-1453.
21. Mosimann UP, Collerton D, Dudley R, et al,. 2008. A semi-structured interview to assess visual hallucinations in older people. Int J Geriatr Psychiatry 23 (7): 712-718.
22. National Collaborating Centre for Chronic Conditions. 2006. Parkinson's Disease: National Clinical Guideline for Diagnosis and Management in Secondary Care. Royal College of Physicians: London.
23. Poewe W,. 2008a. Non-motor symptoms in Parkinson's disease. Eur J Neurol 15 (s1): 14-20.
24. Poewe W,. 2008b. When a Parkinson's disease patient starts to hallucinate. Pract Neurol 8: 238-241.
25. Schwab RS, England AC,. 1969. Progression technique for evaluating surgery for Parkinson's disease. In Third Symposium on Parkinson's Disease, Gillingham FJ, Donaldson MC, (eds). E&S Livingstone: Edinburgh.
26. Sinforiani E, Pacchetti C, Zangaglia R, Pasotti C, Manni R, Nappi G,. 2008. REM behaviour disorder, hallucinations and cognitive impairment in Parkinson's disease: a two-year follow up. Mov Disord 23 (10): 1441-1445.
27. Van Den Eeden SK, Tanner CM, Bernstein AL, et al,. 2003. Incidence of Parkinson's disease: variation by age, gender and race/ethnicity. Am J Epidemiol 157 (11): 1015-1022.
28. Williams DR, Warren JD, Lees AJ,. 2008. Using the presence of visual hallucinations to differentiate Parkinson's disease from atypical parkinsonism. J Neurol Neurosurg Psychiatry 79: 652-655.
29. Zigmond AS, Snaith RP,. 1983. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavia 67: 361-70.